Quality of reporting inflammatory bowel disease randomised controlled trials: a systematic review
Objective Our objective was to perform a systemic evaluation of the risk of bias in randomised controlled trial (RCT) reports published on inflammatory bowel disease (IBD).Design We assessed the risk of bias using the Cochrane tool, as indicators of poor methodology or subsequently poor reporting. W...
Main Authors: | Anthony Akobeng, Svetlana Lakunina, Aditi Rane, Jamal Khudr |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-09-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/11/1/e001337.full |
Similar Items
-
Prepublication abstract-only reports compared with full-text manuscripts for randomised controlled trials in inflammatory bowel disease: a systematic review
by: Gordon William Moran, et al.
Published: (2024-09-01) -
Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation
by: Anthony K. Akobeng, et al.
Published: (2015-09-01) -
Nordic inflammatory bowel disease treatment strategy trial: protocol for the NORDTREAT randomised controlled biomarker-strategy trial
by: Jonas Halfvarson, et al.
Published: (2024-07-01) -
Cognitive-behavioural therapy for the management of inflammatory bowel disease-fatigue: a feasibility randomised controlled trial
by: Micol Artom, et al.
Published: (2019-12-01) -
Hemophagocytic Lymphohistiocytosis and Inflammatory Bowel Disease: Case Report and Systematic Review
by: Bárbara Brambilla, et al.
Published: (2020-03-01)